Search research articles
Contact Us
Filters
Showing results (321-330 of 357) with videos related to
Page
of 36
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
December 11, 2025
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025
Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.
JAMA Network Open
|
June 23, 2026
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design
Ryan E Wiegand, Sean Chickery, Duck-Hye Yang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023
Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
BMJ (Clinical Research Ed.)
|
October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Influenza and Other Respiratory Viruses
|
March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
JAMA Internal Medicine
|
June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults
Ryan E Wiegand, Amanda B Payne, Josephine Mak, et al.
The Journal of Infectious Diseases
|
November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 10, 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study
Stephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, et al.
Vaccine
|
July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021
Peter J Embi, Matthew E Levy, Palak Patel, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 357) with videos related to
Sort By:
Page
of 36
MMWR. Morbidity and Mortality Weekly Report
|
December 11, 2025
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025
Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, et al.
JAMA Network Open
|
June 23, 2026
Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design
Ryan E Wiegand, Sean Chickery, Duck-Hye Yang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023
Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
BMJ (Clinical Research Ed.)
|
October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
Influenza and Other Respiratory Viruses
|
March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
JAMA Internal Medicine
|
June 15, 2026
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults
Ryan E Wiegand, Amanda B Payne, Josephine Mak, et al.
The Journal of Infectious Diseases
|
November 23, 2022
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
Malini B DeSilva, Patrick K Mitchell, Nicola P Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 10, 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study
Stephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, et al.
Vaccine
|
July 21, 2023
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021
Peter J Embi, Matthew E Levy, Palak Patel, et al.
Page
of 36